Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-30 @ 11:56 AM
Study NCT ID:
NCT03558503
Status:
COMPLETED
Last Update Posted:
2022-09-16
First Post:
2018-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
Sponsor:
UroGen Pharma Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TC-BC-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None